Should we be vaccinating children against COVID-19 in high-income countries?

Expert Rev Vaccines. 2021 Sep;20(9):1043-1046. doi: 10.1080/14760584.2021.1951245. Epub 2021 Jul 19.

Authors

Grace Li¹, Adam Finn², Andrew J Pollard¹

Affiliations

¹ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford, UK.
² Bristol Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Level 6, UHBW Education and Research Centre, Bristol, UK.

PMID: 34224291
DOI: 10.1080/14760584.2021.1951245

No abstract available

Keywords: Covid-19; PIMS-TS; Pediatric.

Publication types

Editorial

MeSH terms

Adolescent
BNT162 Vaccine
COVID-19 / complications*
COVID-19 / prevention & control*
COVID-19 / transmission
COVID-19 Vaccines / administration & dosage
COVID-19 Vaccines / immunology*
Carrier State / prevention & control*
Child
Developed Countries
Hospitalization / statistics & numerical data
Humans
Mass Vaccination / ethics*
Post-Acute COVID-19 Syndrome
SARS-CoV-2 / immunology
Systemic Inflammatory Response Syndrome / prevention & control*

Substances

COVID-19 Vaccines
BNT162 Vaccine

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related